% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • billyteex1 billyteex1 Oct 3, 2006 9:58 AM Flag

    20+ Clinicals on AML and CML

    20+ that seems to be a fairly large size commitmented by MOGN. I wonder if the 34% market share Dacogen has achieved indicates a higher vial count than the 1000/week that was announced a few weeks ago? This is just for discussion but at 29%=1000 vials, 34% could equal approx. 1170 vials a week. The news on 34% came out a few weeks after the 1000 vial news so I just trying to get a handle on it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Billy,

      I think you have it wrong...I believe the 34% was equivalent to the reaching the thousand vials...maybe we see a clearer picture at MGI quarter release. That brings me to my next point I think MGI is the play here. Supg long term should be fine and do not want to discourage anyone from it. The pipeline of MGI looks solid. Looks to me SUPG partnered up with a good growth company and with MGI sales force will definitely benefit. When is SUPG quarter update scheduled?